422 related articles for article (PubMed ID: 15716334)
1. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
Troyanov S; Wall CA; Miller JA; Scholey JW; Cattran DC;
J Am Soc Nephrol; 2005 Apr; 16(4):1061-8. PubMed ID: 15716334
[TBL] [Abstract][Full Text] [Related]
2. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
3. Primary FSGS in Nephrotic Adults: Clinical Profile, Response to Immunosuppression and Outcome.
Bagchi S; Agarwal S; Kalaivani M; Bhowmik D; Singh G; Mahajan S; Dinda A
Nephron; 2016; 132(2):81-5. PubMed ID: 26799973
[TBL] [Abstract][Full Text] [Related]
4. The impact of sex in primary glomerulonephritis.
Cattran DC; Reich HN; Beanlands HJ; Miller JA; Scholey JW; Troyanov S;
Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
[TBL] [Abstract][Full Text] [Related]
5. Primary glomerulonephritis: an update on renal survival and determinants of progression.
Moranne O; Watier L; Rossert J; Stengel B;
QJM; 2008 Mar; 101(3):215-24. PubMed ID: 18245806
[TBL] [Abstract][Full Text] [Related]
6. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
Chun MJ; Korbet SM; Schwartz MM; Lewis EJ
J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
[TBL] [Abstract][Full Text] [Related]
7. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis.
Pokhariyal S; Gulati S; Prasad N; Sharma RK; Singh U; Gupta RK; Mittal S; Mehta B
J Nephrol; 2003; 16(5):691-6. PubMed ID: 14733415
[TBL] [Abstract][Full Text] [Related]
8. [Factors predicting for renal survival in primary focal segmental glomerulosclerosis].
Roja JR; Pérez M; Hurtado A; Asato C
Nefrologia; 2008; 28(4):439-46. PubMed ID: 18662153
[TBL] [Abstract][Full Text] [Related]
9. Clinical course of primary focal segmental glomerulosclerosis (FSGS) in Turkish children: a report from the Turkish Pediatric Nephrology FSGS Study Group.
Beşbaş N; Ozaltin F; Emre S; Anarat A; Alpay H; Bakkaloğlu A; Baskin E; Buyan N; Dönmez O; Düşünsel R; Ekim M; Göko F; Gür-Güven A; Kavukçu S; Mir S; Sönmez F
Turk J Pediatr; 2010; 52(3):255-61. PubMed ID: 20718182
[TBL] [Abstract][Full Text] [Related]
10. Primary focal segmental glomerulosclerosis--long-term outcome after pediatric renal transplantation.
Jungraithmayr TC; Bulla M; Dippell J; Greiner C; Griebel M; Leichter HE; Plank C; Tönshoff B; Weber LT; Zimmerhackl LB;
Pediatr Transplant; 2005 Apr; 9(2):226-31. PubMed ID: 15787798
[TBL] [Abstract][Full Text] [Related]
11. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study.
Banfi G; Moriggi M; Sabadini E; Fellin G; D'Amico G; Ponticelli C
Clin Nephrol; 1991 Aug; 36(2):53-9. PubMed ID: 1934660
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic membranous nephropathy: definition and relevance of a partial remission.
Troyanov S; Wall CA; Miller JA; Scholey JW; Cattran DC;
Kidney Int; 2004 Sep; 66(3):1199-205. PubMed ID: 15327418
[TBL] [Abstract][Full Text] [Related]
13. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients?
Deegens JK; Assmann KJ; Steenbergen EJ; Hilbrands LB; Gerlag PG; Jansen JL; Wetzels JF
Neth J Med; 2005 Nov; 63(10):393-8. PubMed ID: 16301760
[TBL] [Abstract][Full Text] [Related]
15. Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy.
Duncan N; Dhaygude A; Owen J; Cairns TD; Griffith M; McLean AG; Palmer A; Taube D
Nephrol Dial Transplant; 2004 Dec; 19(12):3062-7. PubMed ID: 15507477
[TBL] [Abstract][Full Text] [Related]
16. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis?
Ponticelli C; Villa M; Banfi G; Cesana B; Pozzi C; Pani A; Passerini P; Farina M; Grassi C; Baroli A
Am J Kidney Dis; 1999 Oct; 34(4):618-25. PubMed ID: 10516340
[TBL] [Abstract][Full Text] [Related]
17. Tip variant of focal segmental glomerulosclerosis: outcome and comparison to 'not otherwise specified' variant.
Arias LF; Franco-Alzate C; Rojas SL
Nephrol Dial Transplant; 2011 Jul; 26(7):2215-21. PubMed ID: 21068139
[TBL] [Abstract][Full Text] [Related]
18. Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population--epidemiology and outcome.
Deegens JK; Steenbergen EJ; Borm GF; Wetzels JF
Nephrol Dial Transplant; 2008 Jan; 23(1):186-92. PubMed ID: 17704112
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation.
Heinze G; Mitterbauer C; Regele H; Kramar R; Winkelmayer WC; Curhan GC; Oberbauer R
J Am Soc Nephrol; 2006 Mar; 17(3):889-99. PubMed ID: 16481415
[TBL] [Abstract][Full Text] [Related]
20. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study.
Bazzi C; Petrini C; Rizza V; Napodano P; Paparella M; Arrigo G; Pisano L; D'Amico G
Am J Kidney Dis; 2003 Feb; 41(2):328-35. PubMed ID: 12552493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]